Abstract
Candida auris is an emerging multidrug-resistant yeast. We describe an ongoing C. auris outbreak that began in October 2019 in Los Angeles, California, USA. We used genomic analysis to determine that isolates from 5 of 6 patients belonged to clade III; 4 isolates were closely related.
Highlights
Staphylococcus aureusUCLA_A2 dependence, gastrostomy tube bacteremia and multifocal
Candida auris is an emerging multidrug-resistant yeast
Whole-genome sequencing (WGS) of isolates from patients transferred from long-term acute-care (LTAC) facilities revealed that these isolates are closely related, suggesting an ongoing outbreak with community spread in the Los Angeles area
Summary
UCLA_A2 dependence, gastrostomy tube bacteremia and multifocal This patient had a prior history of C. auris colonization at the long-term acute-care facility. Hypertension, hyperlipidemia, Elevated liver enzymes and type 2 diabetes, aplastic gastrointestinal bleeding axillary) anemia, stroke, pulmonary complicated by Enterococcus embolism, pneumothorax, and bacteremia and E. coli urinary coronavirus disease–related tract infection. Pneumonia causing respiratory failure, tracheostomy, and gastrostomy tube dependence. Hypertension, hyperlipidemia, Worsening generalized tracheostomy, and gastrostomy weakness possibly caused by axillary) tube dependence. C. (pleural fluid, tracheostomy, gastrostomy tube auris, Pseudomonas active infection) dependence, stage IV sacral aeruginosa, and Enterococcus decubitus ulcer, and chronic faecalis grew on pleural fluid kidney disease. (pleural fluid, tracheostomy, gastrostomy tube auris, Pseudomonas active infection) dependence, stage IV sacral aeruginosa, and Enterococcus decubitus ulcer, and chronic faecalis grew on pleural fluid kidney disease
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
